Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $2.72 in the prior trading day, Eledon Pharmaceuticals Inc (NASDAQ: ELDN) closed at $2.6, down -4.41%%. In other words, the price has decreased by -$4.41% from its previous closing price. On the day, 0.64 million shares were traded.
Ratios:
Our goal is to gain a better understanding of ELDN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.91 and its Current Ratio is at 13.91. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On January 28, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $9.
Stock Price History:
Over the past 52 weeks, ELDN has reached a high of $5.54, while it has fallen to a 52-week low of $2.30. The 50-Day Moving Average of the stock is -14.11%, while the 200-Day Moving Average is calculated to be -27.77%.
Shares Statistics:
A total of 59.88M shares are outstanding, with a floating share count of 55.34M. Insiders hold about 7.58% of the company’s shares, while institutions hold 59.30% stake in the company.
